Researchers will discuss a gene that appears to play a role in the development of polycystic ovary syndrome, the most common endocrine disorder among reproductive-age women, at upcoming meetings.

Polycystic ovary syndrome is a complex endocrine disorder of unknown aetiology that is characterized by anovulation, excessive amounts or effects of androgens and insulin resistance. The exact ...

A new review in CMAJ (Canadian Medical Association Journal) is aimed at helping clinicians diagnose and manage polycystic ovarian syndrome (PCOS), an endocrine disorder that affects about 10% of ...

Patients with PCOS have higher levels of androgens, leading to increased visceral fat that results in insulin resistance, overall weight gain, and ultimately obesity. This is the second installment of ...

An Endocrine Society task force has developed new guidelines for the treatment of polycystic ovary syndrome (PCOS). The guidelines published online October 24 in the Journal of Clinical Endocrinology ...

Insulin resistance has been found in adolescents with PCOS, however, health care providers are not always testing and monitoring for this early in a female’s life. This is the third installment of a 6 ...

A Clinical Practice Guideline (CPG) was published today for the diagnosis and treatment of polycystic ovary syndrome, the most common hormone disorder in women of reproductive age and a leading cause ...

Please provide your email address to receive an email when new articles are posted on . Polycystic ovary syndrome is a lifelong endocrine, metabolic and reproductive disorder estimated to affect 5% to ...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc., today announced that it has entered into an exclusive license agreement with AstraZeneca for the worldwide development and ...